Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Nucleoside Glycosylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN118373865B details a high-yield nucleoside intermediate route offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Advanced synthesis of Gemcitabine HCl using TBDPS protection for enhanced stability. High-purity nucleoside analogs for pharmaceutical manufacturing with optimized supply chain reliability.
Novel patent CN102311472B offers chromatography-free Clofarabine synthesis. Enhances purity and supply chain reliability for pharmaceutical intermediates.
Patent CN111377989B reveals a high-selectivity synthesis for decitabine intermediates, offering superior beta-isomer ratios and scalable purification for cost-effective API manufacturing.
Novel silanization route for Decitabine intermediates offering high purity and industrial scalability without column chromatography.
Novel scalable route for antisense oligonucleotide intermediates ensuring high purity and cost reduction without preparative chromatography.
Patent CN100383128C discloses an efficient route for capecitabine intermediates, offering significant cost reduction in API manufacturing and improved supply chain reliability.
Patent CN101712708A reveals a scalable Decitabine synthesis using pivaloyl protection, eliminating chromatography for significant cost reduction and high purity.
Patent CN101381387A reveals a cost-effective, stereoselective route for Gemcitabine Hydrochloride, eliminating cryogenic conditions and improving supply chain reliability for API manufacturers.
Patent CN104926806B reveals a robust method for Lamivudine intermediates, offering high purity and scalable manufacturing for global pharmaceutical supply chains.
Patent CN101497639B details a scalable Decitabine synthesis using toluoyl protection and fractional crystallization, offering significant cost reduction in pharmaceutical manufacturing.